home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Understanding Cocaine Cravings

  January, 25 2005 10:45
your information resource in human molecular genetics
For cocaine addicts trying to quit, the challenge lies not just in breaking the habit, but staying off it too. Recovering cocaine addicts are vulnerable to relapsing into drug use, and are more likely to do so after long periods of abstinence than immediately after they stop taking cocaine. Cocaine cravings following an extended withdrawal require the activation of a protein called extracellular-signal regulated kinase (ERK) in a part of the brain involved in motivation and emotion, according to a paper in the February issue of Nature Neuroscience.

Yavin Shaham and colleagues trained rats to press a lever for an intravenous injection of cocaine. They also paired cocaine infusion with specific environmental cues, so that they learned to associate these cues with the drug. The scientists then withheld both cocaine and cocaine-associated cues from the rats for a month. As with human addicts, the rats showed much higher signs of craving when they were exposed to drug-associated environmental cues after 30 days of withdrawal than after one day.

Shaham and colleagues then found that ERK activation in the central nucleus of the amygdala, a brain region known to be involved in motivation and emotion, was necessary for this craving. ERK activation in the amygdala was higher 30 days after withdrawal than 1 day after withdrawal, and blocking ERK activation decreased cocaine-seeking behavior. Moreover, activating ERK 1 day after withdrawal increased the rats' cocaine-seeking behavior. These results identify a specific biochemical pathway in the amygdala underlying this latent craving, giving us insight into the mechanisms of drug relapse.

Author contact:

Yaviv Shaham
National Institute on Drug Abuse, Baltimore, MD, USA.
Tel: 410 550 1746
Email: yshaham@intra.nida.nih.gov

Additional contact for comment on paper:

J. David Sweatt
Baylor College of Medicine, Houston, TX, USA.
Tel: +1 713 798 3107
E-mail: sweatt@bcm.tmc.edu

Also available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.